De novo serine biosynthesis is protective in mitochondrial disease
Christopher B. Jackson(Memorial Sloan Kettering Cancer Center), Anu Suomalainen(University of Helsinki), Christopher J. Carroll(St George's, University of London), Nahid Khan(University of Helsinki), Anastasiia Marmyleva(University of Helsinki), Amy E. Vincent(Muscular Dystrophy UK), Geoffray Monteuuis(University of Helsinki), Takayuki Mito(University of Helsinki), Takashi Tatsuta(Max Planck Institute for Biology of Ageing), Nicola Zamboni(Scuola Internazionale Superiore di Studi Avanzati), Ryan Awadhpersad(University of Helsinki), Liya Wang(Cold Spring Harbor Laboratory), Thomas Langer(University of Cologne)
Cited by 16
Related Papers
Mitochondrial diseases
|Nature Reviews Disease Primers|2016|1.5k
A roadmap for interpreting 13C metabolite labeling patterns from cells
|Current Opinion in Biotechnology|2015|652
Making heads or tails of phospholipids in mitochondria
|The Journal of Cell Biology|2011|580
Mitochondrial quality control: a matter of life and death for neurons
|The EMBO Journal|2012|424
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
|The Lancet Neurology|2011|420